BOSTON, Aug. 06, 2018 /PRNewswire-PRWeb/ -- On June 1, 2018 Saphena Medical Inc. was awarded
"This partnership with Premier is extremely pivotal for our company," says Michael J. Glennon, CEO and Director of Saphena Medical. "We're very excited to have the opportunity to offer lower-cost access to our state-of-the-art Venapax« EVH System, which allows hospitals and doctors to continue delivering safe, lifesaving, effective patient care while maintaining cost control," Glennon adds.
The new agreement will afford doctors and hospitals lower-cost and improved access to Venapax« for use during endoscopic vein harvesting procedures. Venapax« is a single comprehensive solution for endoscopic vein harvesting in the cardiovascular arena.
ABOUT SAPHENA MEDICAL Saphena Medical is a Boston, Massachusetts-based medical device company established in 2013. Its team has deep knowledge in the cardiovascular space, coupled with advanced medical device design and innovation. In 2015, Saphena marketed its first cardiovascular device, the Venapax« Endoscopic Vessel Harvesting System, which consolidates EVH into a single tool.
Michael J. Glennon has been CEO and a Director of Saphena Medical since February 2013.
SOURCE Saphena Medical, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All